Oticon Medical today said the FDA has granted premarket approval for the company’s Neuro Cochlear Implant System. Somerset, N.J.-based Oticon Medical designed the Neuro system to treat people 18 years or older with bilateral severe-to-profound sensorineural hearing loss and who have limited benefits from fitted hearing aids. “At Oticon Medical, we are passionate about using […]
Hologic (NSDQ:HOLX) said yesterday that its CFO Bob McMahon is leaving to take up a CFO role at Agilent Technologies. The Marlborough, Mass.-based company said that its current chief accounting officer Karleen Oberton has been lifted to CFO, effective today. “Bob has made tremendous contributions to Hologic over the last four years, and we wish him […]
Mobile health devices and wearables have increasingly played a prominent role at the annual CES show in Las Vegas. Health and medical devices touted at CES 2018 seek to improve everything from heart health to posture. Here are nine companies exhibiting digital health solutions at this year’s show. Next >>
Oticon said today it launched its internet-of-things connectible Oticon Opn hearing aid, touting its ability to handle noisy environments, reduce cognitive load for users and provide dual communication systems. The newly launched device is designed to handle multiple speech and noise sources, even in complex listening solutions, the Somerset, N.J.-based company said. The newly released hearing […]
Oticon Medical said today it launched the Oticon Opn hearing aid which can connect to mobile phones and other external devices to stream audio, and the company claims is the 1st which can be “connected to the internet of things.” The Somerset, N.J.-based company says the newly released hearing aid features a 30% improvement in speech […]
Oticon Medical this week landed 510(k) clearance from the FDA for its Ponto Plus hearing device.
The Ponto Plus is a bone-anchored sound processor, designed to be used with the company’s proprietary OptiFit/OptiGrip implant design concepts. Built on Oticon’s Inium platform, the device features 2.4 GHz bluetooth wireless technology and is designed to deliver better sound quality, less feedback and fewer artificial sounds, Oticon said.
Stanmore Implants won FDA clearance for an extendible femur implant that can "grow" as the patient does, without the need for surgery, anesthesia or sedation.
The Juvenile Tumour System replaces large portions of the femoral bone in the thigh, which is sometimes removed during cancer treatment.